LEN-B

Lennar Corporation

24
Fundamentals30/ 100
Valuation10/ 100
Upside potential18/ 100
Risk potential51/ 100

LEN-B trails on the overall score without a compensating advantage in the available component scores.

NIO

NIO Inc.

56
Fundamentals77/ 100
Valuation50/ 100
Upside potential58/ 100
Risk potential27/ 100

NIO has the edge over LEN-B overall, supported by stronger fundamentals and stronger valuation.

LEN-B Fundamentals

MetricStatus
Stable
Stable
Stable
Strong

LEN-B's balance sheet is currently strong, and its revenue, profitability and cash flow are stable.

NIO Fundamentals

MetricStatus
Strong
Stable
Stable
Unavailable

NIO's revenue is currently strong, and its profitability and cash flow are stable. There isn't enough data to rate its balance sheet.

LEN-B PE Valuation

CHEAPFAIREXPENSIVE4.3x8.6x13x17x
CHEAPFAIREXPENSIVE4.3x8.6x13x17x
LevelPEPriceVs current
Cheap5.4x$28.56-65%
Fair8.2x$43.53-47%
Expensive11x$57.92-29%
Current15x$81.63—
Forward18x$81.63—

Historical ranges are pointers, not guarantees.

LEN-B's PE is in its expensive range at 15x. Analysts expect earnings to fall, which would put today's price at 18x next year's earnings.

NIO PE Valuation

NIO has no meaningful PE right now: it lost money over the past year.

LEN-B Forward outlook

MetricOutlook
Deteriorating
Decline
Stable
Weakening
Limited
Moderate

Analysts expect LEN-B's earnings and profitability to decline, with its revenue holding steady.

NIO Forward outlook

MetricOutlook
--
Losses shrinking
Growth
Strongly improving
Limited
Moderate

NIO has the edge over LEN-B on the outlook, with more favorable earnings and revenue expectations.

LEN-B Risk to reward

ScenarioChangePrice
Upside+11%$90.79
Downside-51%$39.84

Calculated from the latest close: $81.63 on Nov 12.

LEN-B trails NIO on modeled risk to reward, with less potential upside and more potential downside.

NIO Risk to reward

ScenarioChangePrice
Upside+38%$4.21
Downside-27%$2.22

Calculated from the latest close: $3.05 on Nov 12.

NIO has a better modeled risk to reward balance than LEN-B, with more potential upside and less potential downside.

LEN-B Earnings Per Share

Q4 2023: $13.73Q1 2024: $14.24Q2 2024: $14.68Q3 2024: $15.07Q4 2024: $14.31Q1 2025: $13.70Q2 2025: $12.06Q3 2025: $10.09Q4 2025: $7.98Q1 2026: $6.95Q2 2026: $6.38Q3 2026: $5.28Forward: $4.59
Q4 2023: $13.73Q1 2024: $14.24Q2 2024: $14.68Q3 2024: $15.07Q4 2024: $14.31Q1 2025: $13.70Q2 2025: $12.06Q3 2025: $10.09Q4 2025: $7.98Q1 2026: $6.95Q2 2026: $6.38Q3 2026: $5.28Forward: $4.59
QuarterTTM EPSYoY
Forward$4.59-13%
Q3 2026$5.28-48%
Q2 2026$6.38-47%
Q1 2026$6.95-49%
Q4 2025$7.98-44%
Q3 2025$10.09-33%
Q2 2025$12.06-18%
Q1 2025$13.70-3.8%
Q4 2024$14.31+4.2%

LEN-B has the edge over NIO on earnings quality, reporting a profit while its opponent remains loss making.

NIO Earnings Per Share

Q3 2023: $-1.93Q4 2023: $-1.87Q1 2024: $-1.82Q2 2024: $-1.64Q3 2024: $-1.61Q4 2024: $-1.66Q1 2025: $-1.76Q2 2025: $-1.74Q3 2025: $-1.59Q4 2025: $-1.06Q1 2026: $-0.60Q2 2026: $-0.29
Q3 2023: $-1.93Q4 2023: $-1.87Q1 2024: $-1.82Q2 2024: $-1.64Q3 2024: $-1.61Q4 2024: $-1.66Q1 2025: $-1.76Q2 2025: $-1.74Q3 2025: $-1.59Q4 2025: $-1.06Q1 2026: $-0.60Q2 2026: $-0.29
QuarterTTM EPSYoY
Q2 2026-$0.29+$1.45
Q1 2026-$0.60+$1.16
Q4 2025-$1.06+$0.60
Q3 2025-$1.59+$0.02
Q2 2025-$1.74-$0.10
Q1 2025-$1.76+$0.06
Q4 2024-$1.66+$0.21
Q3 2024-$1.61+$0.32

NIO is still losing money, but far less than before: $0.29 per share over the past year, against $1.93 at its worst in late 2023.

LEN-B Quarterly Revenue

Q4 2023: $11BQ1 2024: $7.3BQ2 2024: $8.8BQ3 2024: $9.4BQ4 2024: $9.9BQ1 2025: $7.6BQ2 2025: $8.4BQ3 2025: $8.8BQ4 2025: $9.4BQ1 2026: $6.6BQ2 2026: $7.9BQ3 2026: $8B
Q4 2023: $11BQ1 2024: $7.3BQ2 2024: $8.8BQ3 2024: $9.4BQ4 2024: $9.9BQ1 2025: $7.6BQ2 2025: $8.4BQ3 2025: $8.8BQ4 2025: $9.4BQ1 2026: $6.6BQ2 2026: $7.9BQ3 2026: $8B
QuarterRevenueYoY
Q3 2026$8B-8.7%
Q2 2026$7.9B-5.2%
Q1 2026$6.6B-13%
Q4 2025$9.4B-5.8%
Q3 2025$8.8B-6.4%
Q2 2025$8.4B-4.4%
Q1 2025$7.6B+4.4%
Q4 2024$9.9B-9.3%

LEN-B's revenue has slid since its 2023 peak: $8B last quarter, down 8.7% from the same quarter a year ago.

NIO Quarterly Revenue

Q3 2023: $2.9BQ4 2023: $2.6BQ1 2024: $1.5BQ2 2024: $2.6BQ3 2024: $2.8BQ4 2024: $3BQ1 2025: $1.8BQ2 2025: $2.9BQ3 2025: $3.3BQ4 2025: $5.2BQ1 2026: $3.8BQ2 2026: $4.8B
Q3 2023: $2.9BQ4 2023: $2.6BQ1 2024: $1.5BQ2 2024: $2.6BQ3 2024: $2.8BQ4 2024: $3BQ1 2025: $1.8BQ2 2025: $2.9BQ3 2025: $3.3BQ4 2025: $5.2BQ1 2026: $3.8BQ2 2026: $4.8B
QuarterRevenueYoY
Q2 2026$4.8B+69%
Q1 2026$3.8B+112%
Q4 2025$5.2B+76%
Q3 2025$3.3B+17%
Q2 2025$2.9B+9%
Q1 2025$1.8B+21%
Q4 2024$3B+15%
Q3 2024$2.8B-2.1%

NIO has the edge over LEN-B on sales, with more consistent year-over-year improvement.

LEN-B Free Cash Flow

Q4 2023: $2.5BQ1 2024: $295MQ2 2024: $203MQ3 2024: $801MQ4 2024: $933MQ1 2025: −$345MQ2 2025: −$1.1BQ3 2025: −$191MQ4 2025: $1.7BQ1 2026: −$463MQ2 2026: −$303MQ3 2026: −$96M
Q4 2023: $2.5BQ1 2024: $295MQ2 2024: $203MQ3 2024: $801MQ4 2024: $933MQ1 2025: −$345MQ2 2025: −$1.1BQ3 2025: −$191MQ4 2025: $1.7BQ1 2026: −$463MQ2 2026: −$303MQ3 2026: −$96M
QuarterFree cash flowYoY
Q3 2026-$96.3M+$94.5M
Q2 2026-$303.2M+$807M
Q1 2026-$463.5M-$118.4M
Q4 2025$1.7B+79%
Q3 2025-$190.8M-124%
Q2 2025-$1.1B-647%
Q1 2025-$345.1M-217%
Q4 2024$933.1M-63%

LEN-B's free cash flow has turned positive again: $811M over the past year, against −$713M the year before.

NIO Free Cash Flow

Q3 2023: --Q4 2023: $137MQ1 2024: $0Q2 2024: −$2.2BQ3 2024: $0Q4 2024: −$391MQ1 2025: $0Q2 2025: −$2.1BQ3 2025: $0Q4 2025: $0Q1 2026: $0Q2 2026: $0
Q3 2023: --Q4 2023: $137MQ1 2024: $0Q2 2024: −$2.2BQ3 2024: $0Q4 2024: −$391MQ1 2025: $0Q2 2025: −$2.1BQ3 2025: $0Q4 2025: $0Q1 2026: $0Q2 2026: $0
QuarterFree cash flowYoY
Q2 2026$0+$2.1B
Q1 2026$0$0
Q4 2025$0+$391.3M
Q3 2025$0$0
Q2 2025-$2.1B+$73.9M
Q1 2025$0$0
Q4 2024-$391.3M-386%
Q2 2024-$2.2B+$337.9M

NIO has the edge over LEN-B on cash flow, with more consistent year-over-year improvement.

LEN-B Total Shares

Q4 2023: 283MQ1 2024: 277MQ2 2024: 274MQ3 2024: 270MQ4 2024: 272MQ1 2025: 263MQ2 2025: 260MQ3 2025: 256MQ4 2025: 258MQ1 2026: 244MQ2 2026: 241MQ3 2026: 238M
Q4 2023: 283MQ1 2024: 277MQ2 2024: 274MQ3 2024: 270MQ4 2024: 272MQ1 2025: 263MQ2 2025: 260MQ3 2025: 256MQ4 2025: 258MQ1 2026: 244MQ2 2026: 241MQ3 2026: 238M
PeriodChange %Net change
Quarterly-1.3%-3M shares
1 year-7%-17.8M shares
3 years-16%-45.1M shares
5 years-23%-69.5M shares
Available history-25%-80.7M shares

LEN-B has the edge over NIO on shareholder dilution, with a more favorable share count trend.

NIO Total Shares

Q3 2023: 1.7BQ4 2023: 1.8BQ1 2024: 2BQ2 2024: 2BQ3 2024: 2.1BQ4 2024: 2.1BQ1 2025: 2.1BQ2 2025: 2.2BQ3 2025: 2.4BQ4 2025: 2.5BQ1 2026: 2.5BQ2 2026: 2.5B
Q3 2023: 1.7BQ4 2023: 1.8BQ1 2024: 2BQ2 2024: 2BQ3 2024: 2.1BQ4 2024: 2.1BQ1 2025: 2.1BQ2 2025: 2.2BQ3 2025: 2.4BQ4 2025: 2.5BQ1 2026: 2.5BQ2 2026: 2.5B
PeriodChange %Net change
Quarterly+0.6%+15.6M shares
1 year+12%+267M shares
3 years+51%+844M shares
5 years+60%+933M shares
Available history+143%+1.5B shares

NIO has 2.5B diluted shares, up 12% from a year ago.

LEN-B Net Leverage

Q4 2023: -1.2xQ1 2024: -1.0xQ2 2024: -0.7xQ3 2024: -0.8xQ4 2024: -1.0xQ1 2025: -0.5xQ2 2025: -0.4xQ3 2025: -0.5xQ4 2025: 0.8xQ1 2026: -1.0xQ2 2026: -1.0xQ3 2026: -0.8x
Q4 2023: -1.2xQ1 2024: -1.0xQ2 2024: -0.7xQ3 2024: -0.8xQ4 2024: -1.0xQ1 2025: -0.5xQ2 2025: -0.4xQ3 2025: -0.5xQ4 2025: 0.8xQ1 2026: -1.0xQ2 2026: -1.0xQ3 2026: -0.8x
QuarterNet LeverageStatus
Q3 2026-0.8xNet Cash
Q2 2026-1.0xNet Cash
Q1 2026-1.0xNet Cash
Q4 20250.8xVery low
Q3 2025-0.5xNet Cash
Q2 2025-0.4xNet Cash
Q1 2025-0.5xNet Cash
Q4 2024-1.0xNet Cash

LEN-B has more cash than debt.

NIO Net Leverage

NIO's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.

LEN-B Weekly Momentum

MetricValueStatus
RSI46.1Neutral
Stochastic70.3Neutral

LEN-B's weekly RSI is 46 (neutral) and its Stochastic is 70 (neutral).

NIO Weekly Momentum

MetricValueStatus
RSI30.7Neutral
Stochastic6.9Oversold

NIO's weekly RSI is 31 (neutral) and its Stochastic is 7 (oversold).

LEN-B PE vs Consumer Cyclical Sector

MetricLEN-BSector medianRelative
PE15x18x14% below
PE %994752 pts above

LEN-B is trading at 15x earnings, a 14% discount to the Consumer Cyclical sector's median of 18x.

NIO PE vs Consumer Cyclical Sector

NIO has no meaningful PE right now: it lost money over the past year.

LEN-B Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$81.30.4% above
20 week MA$82.10.6% below
50 week MA$90.39.6% below
100 week MA$102.921% below
200 week MA$115.329% below

LEN-B has the edge over NIO on trend strength, trading above more of its moving averages.

NIO Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$3.369.2% below
20 week MA$4.0124% below
50 week MA$4.8137% below
100 week MA$4.8537% below
200 week MA$6.0349% below

NIO is in a downtrend: it's below all five of its weekly moving averages, and 49% below its 200-week average.

LEN-B Yearly ROI

YearStart priceEnd priceROI
2020$44.9$64.4+44%
2021$64.4$91.9+43%
2022$91.9$75.1-18%
2023$75.1$134.1+78%
2024$134.1$133.3-0.6%
2025$133.3$97.4-27%
2026 YTD$97.4$81.6-16%

LEN-B has the edge over NIO on returns for 2026, with the stronger performance.

NIO Yearly ROI

YearStart priceEnd priceROI
2020$2.42$45.8+1791%
2021$45.8$30.5-33%
2022$30.5$11.0-64%
2023$11.0$9.07-17%
2024$9.07$4.48-51%
2025$4.48$5.10+14%
2026 YTD$5.10$3.05-40%

NIO's yearly returns have swung widely, from +1791% in 2020 to −64% in 2022. It's down 40% so far in 2026.

Give your agent the market.

Get API key